The consumer is spending a hefty $ 1 billion dollars in CBD, the least you can do is not exaggerate. In this day and age of chemical transparency, labs at every corner per say.
These consumers are after CBD relentlessly to help with pain, depression, anxiety and even cancer, new Digital Citizens Alliance (Digital Citizens) research shows that CBD levels listed on product labels may often be inaccurate, putting consumers at risk and highlighting the need for federal standards and regulation by the U.S. Food and Drug Administration (FDA).
Some circles call it capitalism and they are in their own right. Over more than half of the products purchased and tested by Digital Citizens contained CBD levels that were 20 percent higher or lower than what was listed on the packaging. In a number of cases, CBD levels were less than half, with some containing less than 10 percent, of what the label claimed. That means consumers were receiving essentially a placebo. Shameful.
What makes the findings alarming is that many Americans who take CBD report they did so to replace a prescription medication to treat medical issues including pain, insomnia, anxiety, depression, and, even in some cases, cancer and Alzheimer’s disease. “CBD shows promise to treat pain, anxiety and seizures such as epilepsy. But the market can’t be built on inaccurate CBD levels, misleading claims and a false sense of security about safety,” said Tom Galvin, Executive Director of Digital Citizens. “For consumers to truly trust CBD, they need to know that products meet safety and quality standards backed up by the FDA.
Now if you are giving the people what they paid for, keep in mind that if your product is worth it and has what it states on the label, it is worth it, however if it does not. That is when the issues occur.
According to our sources, and our research, Americans are turning to CBD as a replacement for medication treating serious health issues. When asked, “If you used a CBD product in replacement of a medication, what type of medical issue were you treating?,” CBD users not surprisingly answered pain (53 percent), anxiety (48 percent), and depression (29 percent). They also said they used CBD in place of medication for cancer (9 percent), Alzheimer’s disease (7 percent) and diabetes (7 percent).
Only 1 in 4 Americans who have purchased products containing CBD know that it’s largely unregulated at the federal level. This lack of awareness about the unregulated nature of CBD suggests consumers believe the products meet standards for safety and quality.
The CBD market needs adult supervision, like old school lets give these corporations “powpow” (say it fast).
Why is this happening no federal legalization, of the plant across the board. No standardization,by which these company’s can be held accountable. It is also important that we research the plant. There is no reason why we shouldn’t be researching this topic how you research the Kardashians, there is no excuse as to why you have no even googled CBD.
Without federal legalization the FDA has little to work with. Until then we have to deal with the uncertainty that we may have a facial cream with little to no CBD in it.